{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T06:33:19Z","timestamp":1721543599373},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:00:00Z","timestamp":1335225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s12253-012-9529-5","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T11:33:39Z","timestamp":1335180819000},"page":"749-759","source":"Crossref","is-referenced-by-count":6,"title":["Tissue-Specific Homing of Immune Cells in Malignant Skin Tumors"],"prefix":"10.1007","volume":"18","author":[{"given":"Hajnalka","family":"J\u00f3kai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rta","family":"Marschalk\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Csomor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Szakonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orsolya","family":"Kont\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Barna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarolta","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Holl\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,24]]},"reference":[{"key":"9529_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(01)00261-8","volume":"16","author":"EJ Kunkel","year":"2002","unstructured":"Kunkel EJ, Butcher EC (2002) Chemokines and the tissue-specific migration of lymphocytes. Immunity 16:1\u20134","journal-title":"Immunity"},{"key":"9529_CR2","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ibd.21304","volume":"16","author":"AL Hart","year":"2010","unstructured":"Hart AL, Ng SC, Mann E, Al-Hassi HO, Bernardo D, Knight SC (2010) Homing of immune cells: role in homeostasis and intestinal inflammation. Inflamm Bowel Dis 16:1969\u20131977","journal-title":"Inflamm Bowel Dis"},{"key":"9529_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-60761-461-6_15","volume":"616","author":"PF Lalor","year":"2010","unstructured":"Lalor PF, Curbishley SM, Adams DH (2010) Identifying homing interactions in T-cell traffic in human disease. Methods Mol Biol 616:231\u2013252","journal-title":"Methods Mol Biol"},{"key":"9529_CR4","first-page":"897","volume":"23","author":"EJ Villablanca","year":"2008","unstructured":"Villablanca EJ, Russo V, Mora JR (2008) Dendritic cell migration and lymphocyte homing imprinting. Histol Histopathol 23:897\u2013910","journal-title":"Histol Histopathol"},{"key":"9529_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri2496","volume":"9","author":"DL Woodland","year":"2009","unstructured":"Woodland DL, Kohlmeier JE (2009) Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol 9:153\u2013161","journal-title":"Nat Rev Immunol"},{"key":"9529_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.f.208","volume":"9","author":"H Sigmundsdottir","year":"2008","unstructured":"Sigmundsdottir H, Butcher EC (2008) Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 9:981\u2013987","journal-title":"Nat Immunol"},{"key":"9529_CR7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","volume":"9","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9:679\u2013691","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"9529_CR8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/jid.2009.247","volume":"130","author":"RA Clark","year":"2010","unstructured":"Clark RA (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130(2):362\u2013370","journal-title":"J Invest Dermatol"},{"key":"9529_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tips.2010.03.004","volume":"31","author":"H Sigmundsdottir","year":"2010","unstructured":"Sigmundsdottir H (2010) Improving topical treatments for skin diseases. Trends Pharmacol Sci 31:239\u2013245","journal-title":"Trends Pharmacol Sci"},{"key":"9529_CR10","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood-2005-05-2112","volume":"107","author":"RC Fuhlbrigge","year":"2006","unstructured":"Fuhlbrigge RC, King SL, Sackstein R, Kupper TS (2006) CD43 is a ligand for E-selectin on CLA\u2009+\u2009human T cells. Blood 107:1421\u20131426","journal-title":"Blood"},{"key":"9529_CR11","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1600-0560.2007.00971.x","volume":"35","author":"CM Magro","year":"2008","unstructured":"Magro CM, Dyrsen ME (2008) Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates. J Cutan Pathol 35:1040\u20131049","journal-title":"J Cutan Pathol"},{"key":"9529_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clim.2009.07.010","volume":"133","author":"Z Ni","year":"2009","unstructured":"Ni Z, Walcheck B (2009) Cutaneous lymphocyte-associated antigen (CLA) T cells up-regulate P-selectin ligand expression upon their activation. Clin Immunol 133:257\u2013264","journal-title":"Clin Immunol"},{"key":"9529_CR13","doi-asserted-by":"crossref","unstructured":"Yamanaka K, Dimitroff CJ, Fuhlbrigge RC, Kakeda M, Kurokawa I, Mizutani H, Kupper TS (2008) Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J Allergy Clin Immunol 121:148\u2013157.e3","DOI":"10.1016\/j.jaci.2007.08.014"},{"key":"9529_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","volume":"10","author":"F Baeke","year":"2010","unstructured":"Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10:482\u2013496","journal-title":"Curr Opin Pharmacol"},{"key":"9529_CR15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","volume":"10","author":"T Duhen","year":"2009","unstructured":"Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10:857\u2013863","journal-title":"Nat Immunol"},{"key":"9529_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","volume":"12","author":"A Zlotnik","year":"2000","unstructured":"Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunitiy 12:121\u2013127","journal-title":"Immunitiy"},{"key":"9529_CR17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","volume":"16","author":"R Sabat","year":"2007","unstructured":"Sabat R, Philipp S, H\u00f6flich C, Kreutzer S, Wallace E, Asadullah K, Volk HD, Sterry W, Wolk K (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16:779\u2013798","journal-title":"Exp Dermatol"},{"key":"9529_CR18","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","volume":"176","author":"RA Clark","year":"2006","unstructured":"Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K, Dowgiert RK, Kupper TS (2006) The vast majority of CLA\u2009+\u2009T cells are resident in normal skin. J Immunol 176:4431\u20134439","journal-title":"J Immunol"},{"key":"9529_CR19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.154.4.1543","volume":"154","author":"LF Santamaria Babi","year":"1995","unstructured":"Santamaria Babi LF, Moser R, Perez Soler MT, Picker LJ, Blaser K, Hauser C (1995) Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol 154:1543\u20131550","journal-title":"J Immunol"},{"key":"9529_CR20","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood-2007-05-075176","volume":"110","author":"ST Pals","year":"2007","unstructured":"Pals ST, de Gorter DJ, Spaargaren M (2007) Lymphoma dissemination: the other face of lymphocyte homing. Blood 110:3102\u20133111","journal-title":"Blood"},{"key":"9529_CR21","first-page":"1556","volume":"142","author":"AB Gelb","year":"1993","unstructured":"Gelb AB, Smoller BR, Warnke RA, Picker LJ (1993) Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA). Am J Pathol 142:1556\u20131564","journal-title":"Am J Pathol"},{"key":"9529_CR22","first-page":"705","volume":"29","author":"WH Clark Jr","year":"1969","unstructured":"Clark WH Jr, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705\u2013727","journal-title":"Cancer Res"},{"key":"9529_CR23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","volume":"77","author":"CG Clemente","year":"1996","unstructured":"Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N (1996) Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303\u20131310","journal-title":"Cancer"},{"key":"9529_CR24","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1158\/0008-5472.CAN-04-2059","volume":"64","author":"IM Mullins","year":"2004","unstructured":"Mullins IM, Slingluff CL, Lee JK, Garbee CF, Shu J, Anderson SG, Mayer ME, Knaus WA, Mullins DW (2004) CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease. Cancer Res 64:7697\u20137701","journal-title":"Cancer Res"},{"key":"9529_CR25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000658-198104000-00007","volume":"193","author":"CL Day Jr","year":"1981","unstructured":"Day CL Jr, Sober AJ, Kopf AW, Lew RA, Mihm MC Jr, Hennessey P, Golomb FM, Harris MN, Gumport SL, Raker JW, Malt RA, Cosimi AB, Wood WC, Roses DF, Gorstein F, Postel A, Grier WR, Mintzis MN, Fitzpatrick TB (1981) A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg 193:436\u2013440","journal-title":"Ann Surg."},{"key":"9529_CR26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1309\/WBF7-N8KH-71KT-RVQ9","volume":"118","author":"RJ Tuthill","year":"2002","unstructured":"Tuthill RJ, Unger JM, Liu PY, Flaherty LE, Sondak VK (2002) Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model. Am J Clin Pathol 118:504\u2013511","journal-title":"Am J Clin Pathol."},{"key":"9529_CR27","first-page":"3","volume":"9","author":"DA Oble","year":"2009","unstructured":"Oble DA, Loewe R, Yu P, Mihm MC Jr (2009) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 9:3","journal-title":"Cancer Immun."},{"key":"9529_CR28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2006.08.9755","volume":"25","author":"RC Taylor","year":"2007","unstructured":"Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS (2007) Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 25:869\u2013875","journal-title":"J Clin Oncol"},{"key":"9529_CR29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CJI.0b013e3181d367bd","volume":"33","author":"PA Prieto","year":"2010","unstructured":"Prieto PA, Durflinger KH, Wunderlich JR, Rosenberg SA, Dudley ME (2010) Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy. J Immunother 33:547\u2013556","journal-title":"J Immunother"},{"key":"9529_CR30","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4049\/jimmunol.173.2.1444","volume":"173","author":"M Viguier","year":"2004","unstructured":"Viguier M, Lema\u00eetre F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L (2004) Foxp3 expressing CD4\u2009+\u2009CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173:1444\u20131453","journal-title":"J Immunol"},{"key":"9529_CR31","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1158\/1078-0432.CCR-06-2450","volume":"13","author":"C Weishaupt","year":"2007","unstructured":"Weishaupt C, Munoz KN, Buzney E, Kupper TS, Fuhlbrigge RC (2007) T-cell distribution and adhesion receptor expression in metastatic melanoma. Clin Cancer Res 13:2549\u20132556","journal-title":"Clin Cancer Res"},{"key":"9529_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","volume":"8","author":"SA Rosenberg","year":"2008","unstructured":"Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8:299\u2013308","journal-title":"Nat Rev Cancer"},{"key":"9529_CR33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/157339408784310142","volume":"4","author":"N Labarriere","year":"2008","unstructured":"Labarriere N, Dreno B, Jotereau F (2008) Lymphocyte biomarkers of clinical responses to adoptive immunotherapy of malignant melanoma. Curr Cancer Ther Rev 4:125\u2013129","journal-title":"Curr Cancer Ther Rev"},{"key":"9529_CR34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","volume":"6","author":"L Gattinoni","year":"2006","unstructured":"Gattinoni L, Powell DJ Jr, Rosenberg SA, Restifo NP (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6:383\u2013393","journal-title":"Nat Rev Immunol"},{"key":"9529_CR35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/bjc.1997.245","volume":"75","author":"DH Adams","year":"1997","unstructured":"Adams DH, Yannelli JR, Newman W, Lawley T, Ades E, Rosenberg SA, Shaw S (1997) Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis. Br J Cancer 75:1421\u20131431","journal-title":"Br J Cancer"},{"key":"9529_CR36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/1523-1747.ep12499959","volume":"98","author":"D Rohde","year":"1992","unstructured":"Rohde D, Schl\u00fcter-Wigger W, Mielke V, von den Driesch P, von Gaudecker B, Sterry W (1992) Infiltration of both T cells and neutrophils in the skin is accompanied by the expression of endothelial leukocyte adhesion molecule-1 (ELAM-1): an immunohistochemical and ultrastructural study. J Invest Dermatol 98:794\u2013799","journal-title":"J Invest Dermatol"},{"key":"9529_CR37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/jnci\/87.5.366","volume":"87","author":"D Schadendorf","year":"1995","unstructured":"Schadendorf D, Heidel J, Gawlik C, Suter L, Czarnetzki BM (1995) Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 87:366\u2013371","journal-title":"J Natl Cancer Inst"},{"key":"9529_CR38","first-page":"679","volume":"152","author":"PT Nooijen","year":"1998","unstructured":"Nooijen PT, Westphal JR, Eggermont AM, Schalkwijk C, Max R, de Waal RM, Ruiter DJ (1998) Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. Am J Pathol 152:679\u2013682","journal-title":"Am J Pathol"},{"key":"9529_CR39","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1084\/jem.20080099","volume":"205","author":"SA Quezada","year":"2008","unstructured":"Quezada SA, Peggs KS, Simpson TR, Shen Y, Littman DR, Allison JP (2008) Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J Exp Med 205:2125\u20132138","journal-title":"J Exp Med"},{"key":"9529_CR40","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/ATVBAHA.109.186742","volume":"29","author":"TE Walshe","year":"2009","unstructured":"Walshe TE, Dole VS, Maharaj AS, Patten IS, Wagner DD, D'Amore PA (2009) Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling. Arterioscler Thromb Vasc Biol 29:1185\u20131192","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9529_CR41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mvr.2010.03.003","volume":"80","author":"TE Walshe","year":"2010","unstructured":"Walshe TE (2010) TGF-beta and microvessel homeostasis. Microvasc Res 80:166\u2013173","journal-title":"Microvasc Res"},{"key":"9529_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02893437","volume":"13","author":"J Kiss","year":"2007","unstructured":"Kiss J, T\u00edm\u00e1r J, Somlai B, Gilde K, Fej\u00f4s Z, Gaudi I, Lad\u00e1nyi A (2007) Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma. Pathol Oncol Res 13:21\u201331","journal-title":"Pathol Oncol Res"},{"key":"9529_CR43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI34431","volume":"118","author":"GM Barton","year":"2008","unstructured":"Barton GM (2008) A calculated response: control of inflammation by the innate immune system. J Clin Invest 118:413\u2013420","journal-title":"J Clin Invest"},{"key":"9529_CR44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.semcancer.2008.10.011","volume":"19","author":"C Krieg","year":"2009","unstructured":"Krieg C, Boyman O (2009) The role of chemokines in cancer immune surveillance by the adaptive immune system. Semin Cancer Biol 19:76\u201383","journal-title":"Semin Cancer Biol"},{"key":"9529_CR45","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF (2009) Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 69:3077\u20133085","journal-title":"Cancer Res"},{"key":"9529_CR46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2008.10.012","volume":"19","author":"AA Navarini-Meury","year":"2009","unstructured":"Navarini-Meury AA, Conrad C (2009) Melanoma and innate immunity\u2013aActive inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines. Semin Cancer Biol 19:84\u201391","journal-title":"Semin Cancer Biol"},{"key":"9529_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1755-148X.2009.00554.x","volume":"22","author":"A Richmond","year":"2009","unstructured":"Richmond A, Yang J, Su Y (2009) The good and the bad of chemokines\/chemokine receptors in melanoma. Pigment Cell Melanoma Res 22:175\u2013186","journal-title":"Pigment Cell Melanoma Res"},{"key":"9529_CR48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2008.11.002","volume":"19","author":"R Somasundaram","year":"2009","unstructured":"Somasundaram R, Herlyn D (2009) Chemokines and the microenvironment in neuroectodermal tumor-host interaction. Semin Cancer Biol 19:92\u201396","journal-title":"Semin Cancer Biol"},{"key":"9529_CR49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2003.10.006","volume":"14","author":"RM Strieter","year":"2004","unstructured":"Strieter RM, Belperio JA, Phillips RJ, Keane MP (2004) CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 14:195\u2013200","journal-title":"Semin Cancer Biol"},{"key":"9529_CR50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cytogfr.2005.04.007","volume":"16","author":"RM Strieter","year":"2005","unstructured":"Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP (2005) CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16:593\u2013609","journal-title":"Cytokine Growth Factor Rev"},{"key":"9529_CR51","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","volume":"187","author":"KE Cole","year":"1998","unstructured":"Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K (1998) Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187:2009\u20132021","journal-title":"J Exp Med"},{"key":"9529_CR52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I","volume":"189","author":"M Kunz","year":"1999","unstructured":"Kunz M, Toksoy A, Goebeler M, Engelhardt E, Brocker E, Gillitzer R (1999) Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma. J Pathol 189:552\u2013558","journal-title":"J Pathol"},{"key":"9529_CR53","first-page":"9","volume":"140","author":"DT Graves","year":"1992","unstructured":"Graves DT, Barnhill R, Galanopoulos T, Antoniades HN (1992) Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 140:9\u201314","journal-title":"Am J Pathol"},{"key":"9529_CR54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0960-9822(01)00199-3","volume":"11","author":"M Mellado","year":"2001","unstructured":"Mellado M, de Ana AM, Moreno MC, Martinez C, Rodriguez-Frade JM (2001) A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death. Curr Biol 11:691\u2013696","journal-title":"Curr Biol"},{"key":"9529_CR55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI7548","volume":"105","author":"T Fushimi","year":"2000","unstructured":"Fushimi T, Kojima A, Moore MA, Crystal RG (2000) Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. J Clin Invest 105:1383\u20131393","journal-title":"J Clin Invest"},{"key":"9529_CR56","first-page":"6997","volume":"62","author":"MS Brose","year":"2002","unstructured":"Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, Davies H, Cox C, Brignell G, Stephens P, Futreal PA, Wooster R, Stratton MR, Weber BL (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62:6997\u20137000","journal-title":"Cancer Res"},{"key":"9529_CR57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10555-005-1577-9","volume":"24","author":"GP Robertson","year":"2005","unstructured":"Robertson GP (2005) Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev 24:273\u2013285","journal-title":"Cancer Metastasis Rev"},{"key":"9529_CR58","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.1158\/0008-5472.CAN-10-0705","volume":"70","author":"KM Hardy","year":"2010","unstructured":"Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Strizzi L, Hendrix MJ (2010) Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70:10340\u201310350","journal-title":"Cancer Res"},{"key":"9529_CR59","first-page":"1","volume":"2010","author":"CH Yang","year":"2010","unstructured":"Yang CH, Fan M, Slominski AT, Yue J, Pfeffer LM (2010) The role of constitutively activated STAT3 in B16 melanoma cells. Int J Interferon Cytokine Mediator Res 2010:1\u20137","journal-title":"Int J Interferon Cytokine Mediator Res"},{"key":"9529_CR60","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.jid.5700199","volume":"126","author":"RA Clark","year":"2006","unstructured":"Clark RA, Chong BF, Mirchandani N, Yamanaka K, Murphy GF, Dowgiert RK, Kupper TS (2006) A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 126:1059\u20131070","journal-title":"J Invest Dermatol"},{"key":"9529_CR61","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1084\/jem.20071190","volume":"205","author":"RA Clark","year":"2008","unstructured":"Clark RA, Huang SJ, Murphy GF, Mollet IG, Hijnen D, Muthukuru M, Schanbacher CF, Edwards V, Miller DM, Kim JE, Lambert J, Kupper TS (2008) Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med 205:2221\u20132234","journal-title":"J Exp Med"},{"key":"9529_CR62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01516999","volume":"41","author":"J Hald","year":"1995","unstructured":"Hald J, Rasmussen N, Claesson MH (1995) Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck. Cancer Immunol Immunother 41:243\u2013250","journal-title":"Cancer Immunol Immunother"},{"key":"9529_CR63","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood-2006-01-0177","volume":"108","author":"S Wei","year":"2006","unstructured":"Wei S, Kryczek I, Zou W (2006) Regulatory T-cell compartmentalization and trafficking. Blood 108:426\u2013431","journal-title":"Blood"},{"issue":"Suppl 66","key":"9529_CR64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.0366-077X.2003.05630.x","volume":"149","author":"R Dummer","year":"2003","unstructured":"Dummer R, Urosevic M, Kempf W, Hoek K, Hafner J, Burg G (2003) Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol 149(Suppl 66):57\u201358","journal-title":"Br J Dermatol"},{"key":"9529_CR65","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/archderm.139.10.1325","volume":"139","author":"M Urosevic","year":"2003","unstructured":"Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R (2003) Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol 139:1325\u20131332","journal-title":"Arch Dermatol"},{"key":"9529_CR66","first-page":"252","volume":"8","author":"M Verhaegh","year":"1998","unstructured":"Verhaegh M, Beljaards R, Veraart J, Hoekzema R, Neumann M (1998) Adhesion molecule expression in basal cell carcinoma. Eur J Dermatol 8:252\u2013255","journal-title":"Eur J Dermatol"},{"key":"9529_CR67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<351::AID-PATH227>3.0.CO;2-6","volume":"187","author":"AJ Kooy","year":"1999","unstructured":"Kooy AJ, Prens EP, Van Heukelum A, Vuzevski VD, Van Joost T, Tank B (1999) Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10? J Pathol 187:351\u2013357","journal-title":"J Pathol"},{"key":"9529_CR68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<169::AID-PATH976>3.0.CO;2-G","volume":"184","author":"AJ Kooy","year":"1998","unstructured":"Kooy AJ, Tank B, Vuzevski VD, van Joost T, Prens EP (1998) Expression of interferongamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma; decreased expression of IFNgamma R and shedding of ICAM-1 as a means to escape immune surveillance. J Pathol 184:169\u2013176","journal-title":"J Pathol"},{"key":"9529_CR69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1529-8019.2005.05008.x","volume":"18","author":"BT Kovach","year":"2005","unstructured":"Kovach BT, Stasko T (2005) Use of topical immunomodulators in organ transplant recipients. Dermatol Ther 18:19\u201327","journal-title":"Dermatol Ther"},{"key":"9529_CR70","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2230.2004.01614.x","volume":"29","author":"RS Barnetson","year":"2004","unstructured":"Barnetson RS, Satchell A, Zhuang L, Slade HB, Halliday GM (2004) Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells. Clin Exp Dermatol 29:639\u2013643","journal-title":"Clin Exp Dermatol"},{"key":"9529_CR71","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-4632.2009.03916.x","volume":"48","author":"V Giorgi De","year":"2009","unstructured":"De Giorgi V, Salvini C, Chiarugi A, Paglierani M, Maio V, Nicoletti P, Santucci M, Carli P, Massi D (2009) In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma. Int J Dermatol 48:312\u2013321","journal-title":"Int J Dermatol"},{"issue":"Suppl 1","key":"9529_CR72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-4632.2002.00020.x","volume":"41","author":"S Salasche","year":"2002","unstructured":"Salasche S (2002) Imiquimod 5\u00a0% cream: a new treatment option for basal cell carcinoma. Int J Dermatol 41(Suppl 1):16\u201320","journal-title":"Int J Dermatol"},{"key":"9529_CR73","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1038\/sj.jid.5700884","volume":"127","author":"HG Kaporis","year":"2007","unstructured":"Kaporis HG, Guttman-Yassky E, Lowes MA, Haider AS, Fuentes-Duculan J, Darabi K, Whynot-Ertelt J, Khatcherian A, Cardinale I, Novitskaya I, Krueger JG, Carucci JA (2007) Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 127:2391\u20132398","journal-title":"J Invest Dermatol"},{"key":"9529_CR74","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI200524826","volume":"115","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M, Rook AH (2005) Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 115:798\u2013812","journal-title":"J Clin Invest"},{"key":"9529_CR75","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","volume":"105","author":"CL Berger","year":"2005","unstructured":"Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL (2005) Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105:1640\u20131647","journal-title":"Blood"},{"key":"9529_CR76","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/jid.2009.290","volume":"129","author":"RA Clark","year":"2009","unstructured":"Clark RA (2009) Regulation gone wrong: a subset of S\u00e9zary patients have malignant regulatory T cells. J Invest Dermatol 129:2747\u20132750","journal-title":"J Invest Dermatol"},{"key":"9529_CR77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1078-0432.CCR-07-0610","volume":"14","author":"BF Chong","year":"2008","unstructured":"Chong BF, Wilson AJ, Gibson HM, Hafner MS, Luo Y, Hedgcock CJ, Wong HK (2008) Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma\/mycosis fungoides. Clin Cancer Res 14:646\u2013653","journal-title":"Clin Cancer Res"},{"key":"9529_CR78","first-page":"594","volume":"9","author":"M Beyer","year":"2011","unstructured":"Beyer M, M\u00f6bs M, Humme D, Sterry W (2011) Pathogenesis of mycosis fungoides. J Dtsch Dermatol Ges 9:594\u2013598","journal-title":"J Dtsch Dermatol Ges"},{"key":"9529_CR79","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1038\/jid.2009.175","volume":"129","author":"JB Heid","year":"2009","unstructured":"Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E, Klemke CD (2009) FOXP3\u2009+\u2009CD25- tumor cells with regulatory function in S\u00e9zary syndrome. J Invest Dermatol 129:2875\u20132885","journal-title":"J Invest Dermatol"},{"key":"9529_CR80","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/10428190802064917","volume":"49","author":"E Capriotti","year":"2008","unstructured":"Capriotti E, Vonderheid EC, Thoburn CJ, Wasik MA, Bahler DW, Hess AD (2008) Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. Leuk Lymphoma 49:1190\u20131201","journal-title":"Leuk Lymphoma"},{"key":"9529_CR81","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/leu.2008.224","volume":"22","author":"T Krejsgaard","year":"2008","unstructured":"Krejsgaard T, Gjerdrum LM, Ralfkiaer E, Lauenborg B, Eriksen KW, Mathiesen AM, Bovin LF, Gniadecki R, Geisler C, Ryder LP, Zhang Q, Wasik MA, Odum N, Woetmann (2008) A Malignant Tregs express low molecular splice forms of FOXP3 in S\u00e9zary syndrome. Leukemia 22:2230\u20132239","journal-title":"Leukemia"},{"key":"9529_CR82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.2009.09364.x","volume":"162","author":"JD Bouaziz","year":"2010","unstructured":"Bouaziz JD, Remtoula N, Bensussan A, Marie-Cardine A, Bagot M (2010) Absolute CD3+ CD158k\u2009+\u2009lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumor burden in S\u00e9zary syndrome. Br J Dermatol 162:123\u2013128","journal-title":"Br J Dermatol"},{"key":"9529_CR83","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell JJ, Clark RA, Watanabe R, Kupper TS (2010) Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 116:767\u2013771","journal-title":"Blood"},{"key":"9529_CR84","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.20922","volume":"115","author":"M Notohamiprodjo","year":"2005","unstructured":"Notohamiprodjo M, Segerer S, Huss R, Hildebrandt B, Soler D, Djafarzadeh R, Buck W, Nelson PJ, von Luettichau I (2005) CCR10 is expressed in cutaneous T-cell lymphoma. Int J Cancer 115:641\u2013647","journal-title":"Int J Cancer"},{"key":"9529_CR85","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","volume":"371","author":"ST Hwang","year":"2008","unstructured":"Hwang ST, Janik JE, Jaffe ES, Wilson WH (2008) Mycosis fungoides and S\u00e9zary syndrome. Lancet 371:945\u2013957","journal-title":"Lancet"},{"key":"9529_CR86","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","volume":"107","author":"MG Narducci","year":"2006","unstructured":"Narducci MG, Scala E, Bresin A, Caprini E, Picchio MC, Remotti D, Ragone G, Nasorri F, Frontani M, Arcelli D, Volinia S, Lombardo GA, Baliva G, Napolitano M, Russo G (2006) Skin homing of S\u00e9zary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV. Blood 107:1108\u20131115","journal-title":"Blood"},{"key":"9529_CR87","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/jid.2009.45","volume":"129","author":"XS Wu","year":"2009","unstructured":"Wu XS, Lonsdorf AS, Hwang ST (2009) Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors. J Invest Dermatol 129:1115\u20131119","journal-title":"J Invest Dermatol"},{"key":"9529_CR88","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1038\/sj.jid.5700916","volume":"127","author":"E Capriotti","year":"2007","unstructured":"Capriotti E, Vonderheid EC, Thoburn CJ, Bright EC, Hess AD (2007) Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations. J Invest Dermatol 127:2882\u20132892","journal-title":"J Invest Dermatol"},{"key":"9529_CR89","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","volume":"152","author":"M Sokolowska-Wojdylo","year":"2005","unstructured":"Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abuzahra F, Bowman E, Roszkiewicz J, Bieber T, T\u00fcting T (2005) Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 152:258\u2013264","journal-title":"Br J Dermatol"},{"key":"9529_CR90","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V95.6.1900","volume":"95","author":"P Drillenburg","year":"2000","unstructured":"Drillenburg P, Pals ST (2000) Cell adhesion receptors in lymphoma dissemination. Blood 95:1900\u20131910","journal-title":"Blood"},{"key":"9529_CR91","first-page":"859","volume":"7","author":"MJ Borowitz","year":"1993","unstructured":"Borowitz MJ, Weidner A, Olsen EA, Picker LJ (1993) Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease. Leukemia 7:859\u2013863","journal-title":"Leukemia"},{"key":"9529_CR92","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1523-1747.ep12364814","volume":"101","author":"PW Heald","year":"1993","unstructured":"Heald PW, Yan SL, Edelson RL, Tigelaar R, Picker LJ (1993) Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 101:222\u2013226","journal-title":"J Invest Dermatol"},{"key":"9529_CR93","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4049\/jimmunol.172.3.1575","volume":"172","author":"BF Chong","year":"2004","unstructured":"Chong BF, Murphy JE, Kupper TS, Fuhlbrigge RC (2004) E-selectin, thymus- and activation-regulated chemokine\/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system. J Immunol 172:1575\u20131581","journal-title":"J Immunol"},{"key":"9529_CR94","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/0008-5472.CAN-08-2891","volume":"69","author":"C Hoeller","year":"2009","unstructured":"Hoeller C, Richardson SK, Ng LG, Valero T, Wysocka M, Rook AH, Weninger W (2009) In vivo imaging of cutaneous T-cell lymphoma migration to the skin. Cancer Res 69:2704\u20132708","journal-title":"Cancer Res"},{"key":"9529_CR95","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1607-551X(09)70019-1","volume":"24","author":"CS Wu","year":"2008","unstructured":"Wu CS, Wang ST, Liao CY, Wu MT (2008) Differential CCR4 expression and function in cutaneous T-cell lymphoma cell lines. Kaohsiung J Med Sci 24:577\u2013590","journal-title":"Kaohsiung J Med Sci"},{"key":"9529_CR96","first-page":"13","volume":"14","author":"LF Santamaria-Bab\u00ed","year":"2004","unstructured":"Santamaria-Bab\u00ed LF (2004) CLA(+) T cells in cutaneous diseases. Eur J Dermatol 14:13\u201318","journal-title":"Eur J Dermatol"},{"key":"9529_CR97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","volume":"43","author":"H Saeki","year":"2006","unstructured":"Saeki H, Tamaki K (2006) Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases. J Dermatol Sci 43:75\u201384","journal-title":"J Dermatol Sci"},{"key":"9529_CR98","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.pas.0000213267.92349.59","volume":"30","author":"H Yagi","year":"2006","unstructured":"Yagi H, Seo N, Ohshima A, Itoh T, Itoh N, Horibe T, Yoshinari Y, Takigawa M, Hashizume H (2006) Chemokine receptor expression in cutaneous T cell and NK\/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol 30:1111\u20131119","journal-title":"Am J Surg Pathol"},{"key":"9529_CR99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","volume":"48","author":"T Kakinuma","year":"2003","unstructured":"Kakinuma T, Sugaya M, Nakamura K, Kaneko F, Wakugawa M, Matsushima K, Tamaki K (2003) Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48:23\u201330","journal-title":"J Am Acad Dermatol"},{"key":"9529_CR100","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","volume":"119","author":"K Ferenczi","year":"2002","unstructured":"Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS (2002) Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119:1405\u20131410","journal-title":"J Invest Dermatol"},{"key":"9529_CR101","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000096191","volume":"213","author":"MT Fierro","year":"2006","unstructured":"Fierro MT, Comessatti A, Quaglino P, Ortoncelli M, Osella Abate S, Ponti R, Novelli M, Bernengo MG (2006) Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and S\u00e9zary syndrome. Dermatology 213:284\u2013292","journal-title":"Dermatology"},{"key":"9529_CR102","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jdermsci.2010.05.005","volume":"59","author":"M Sugaya","year":"2010","unstructured":"Sugaya M (2010) Chemokines and cutaneous lymphoma. J Dermatol Sci 59:81\u201385","journal-title":"J Dermatol Sci"},{"key":"9529_CR103","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.jid.5700246","volume":"126","author":"S Kagami","year":"2006","unstructured":"Kagami S, Sugaya M, Minatani Y, Ohmatsu H, Kakinuma T, Fujita H, Tamaki K (2006) Elevated serum CTACK\/CCL27 levels in CTCL. J Invest Dermatol 126:1189\u20131191","journal-title":"J Invest Dermatol"},{"key":"9529_CR104","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1158\/1078-0432.CCR-05-1513","volume":"12","author":"Y Fujita","year":"2006","unstructured":"Fujita Y, Abe R, Sasaki M, Honda A, Furuichi M, Asano Y, Norisugi O, Shimizu T, Shimizu H (2006) Presence of circulating CCR10+ T cells and elevated serum CTACK\/CCL27 in the early stage of mycosis fungoides. Clin Cancer Res 12:2670\u20132675","journal-title":"Clin Cancer Res"},{"key":"9529_CR105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","volume":"115","author":"D Lu","year":"2001","unstructured":"Lu D, Duvic M, Medeiros LJ, Luthra R, Dorfman DM, Jones D (2001) The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol 115:413\u2013421","journal-title":"Am J Clin Pathol"},{"key":"9529_CR106","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1046\/j.1523-1747.2003.12555.x","volume":"121","author":"T Kallinich","year":"2003","unstructured":"Kallinich T, Muche JM, Qin S, Sterry W, Audring H, Kroczek RA (2003) Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 121:1045\u20131052","journal-title":"J Invest Dermatol"},{"key":"9529_CR107","first-page":"553","volume":"13","author":"T Yamaguchi","year":"2003","unstructured":"Yamaguchi T, Ohshima K, Tsuchiya T, Suehuji H, Karube K, Nakayama J, Suzumiya J, Yoshino T, Kikuchi M (2003) The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2- associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia\/lymphoma. Eur J Dermatol 13:553\u2013559","journal-title":"Eur J Dermatol"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-012-9529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-012-9529-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-012-9529-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T06:25:54Z","timestamp":1687415154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-012-9529-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,24]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9529"],"URL":"https:\/\/doi.org\/10.1007\/s12253-012-9529-5","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,24]]}}}